Pulse Biosciences Inc (PLSE) FY2025Q4 Earning Prediction
Pulse Biosciences Inc (PLSE) is set to release its earnings performance on 02/19 05:00:00 in After Hours trading. Consensus forecasts predict a revenue of 750.00K and an earnings per share (EPS) of -0.32 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
PLSE Transcript
The earnings call highlights significant challenges: a GAAP net loss of $19.4 million, high cash burn, and competitive pressures. Despite initial revenue from product launches, financial sustainability is a concern. The Q&A reveals uncertainties in strategic partnerships and trial outcomes. These factors, coupled with increased costs and competitive risks, suggest a negative sentiment. Without strong guidance or partnerships, the stock is likely to face downward pressure.
The earnings call highlights strong strategic developments, including a new partnership in cardiac ablation and compatibility with major mapping systems. Despite increased expenses and net losses, the company maintains a solid cash position, indicating disciplined financial management. The positive aspects, such as the partnership and product compatibility, outweigh the negatives, suggesting a likely positive stock reaction.
The earnings call presents a mixed picture. Strong clinical progress and FDA clearances are positive, but the financials show widening losses and increased expenses, which are concerning. The market strategy shows promise, but regulatory and competitive risks remain. The Q&A section didn't reveal additional negative sentiment. Given the balance of positive clinical developments and financial concerns, the stock price is likely to remain stable in the near term, resulting in a neutral prediction.
The earnings call summary highlights strong product development, market expansion, and a solid financial position with $118 million in cash. Despite a GAAP net loss, the company shows promising clinical results, FDA clearances, and a significant market opportunity in atrial fibrillation. The lack of questions in the Q&A suggests no immediate concerns. These factors suggest a positive stock reaction, with expected growth in market share and commercialization efforts.
PLSE Report
Frequently Asked Questions
What is the Pulse Biosciences Inc FY2025Q4 Earnings Release Date and Time?
Pulse Biosciences Inc (PLSE) is scheduled to release its FY2025Q4 earnings report onFeb 19, 2026, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Pulse Biosciences Inc FY2025Q4 Revenue and EPS?
Analysts' consensus predicts 750.00K in revenue and an EPS of -0.32 for Pulse Biosciences Inc's FY2025Q4.
What Does Intellectia's AI Predict for Pulse Biosciences Inc FY2025Q4 Earnings?
Intellectia's exclusive AI algorithms forecast a forPulse Biosciences Inc's FY2025Q4 earnings, with a prediction date of Feb 19, 2026. Pulse Biosciences Inc
How Can I Use This Earnings Prediction to Trade PLSE Stock?
Leverage Intellectia's AI forecast to position trades ahead of theFeb 19, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Pulse Biosciences Inc FY2025Q4?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
